Articles

Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells’ vulnerability to DNA-damaging agents

Chair of Hematology, Department of Internal Medicine (DiMI), University of Genova, Italy;Hematology Unit, Policlinico San Martino, Genova, Italy
Chair of Hematology, Department of Internal Medicine (DiMI), University of Genova, Italy
European Institute of Oncology, Milan, Italy
European Institute of Oncology, Milan, Italy
Chair of Hematology, Department of Internal Medicine (DiMI), University of Genova, Italy
Chair of Hematology, Department of Internal Medicine (DiMI), University of Genova, Italy
Chair of Hematology, Department of Internal Medicine (DiMI), University of Genova, Italy;Hematology Unit, Policlinico San Martino, Genova, Italy
Chair of Hematology, Department of Internal Medicine (DiMI), University of Genova, Italy
Chair of Hematology, Department of Internal Medicine (DiMI), University of Genova, Italy
Chair of Hematology, Department of Internal Medicine (DiMI), University of Genova, Italy;Hematology Unit, Policlinico San Martino, Genova, Italy
Chair of Hematology, Department of Internal Medicine (DiMI), University of Genova, Italy;Hematology Unit, Policlinico San Martino, Genova, Italy
Chair of Hematology, Department of Internal Medicine (DiMI), University of Genova, Italy
Service and Central Laboratory of Hematology, University Hospital of Lausanne, Switzerland
Service and Central Laboratory of Hematology, University Hospital of Lausanne, Switzerland
Laboratory of Pre-Clinical and Translational Research, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Potenza, Italy
Department of Oncology and Hemato-Oncology, University of Milan, Italy;Hematology Unit, Fondazione Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy
Department of Experimental Medicine, University of Genova, Italy and
Department of Experimental Medicine, University of Genova, Italy and
Hematology Unit, Policlinico San Martino, Genova, Italy;Department of Internal Medicine, University of Genova, Italy
European Institute of Oncology, Milan, Italy
Chair of Hematology, Department of Internal Medicine (DiMI), University of Genova, Italy;Hematology Unit, Policlinico San Martino, Genova, Italy
Chair of Hematology, Department of Internal Medicine (DiMI), University of Genova, Italy;Hematology Unit, Policlinico San Martino, Genova, Italy
Chair of Hematology, Department of Internal Medicine (DiMI), University of Genova, Italy;Hematology Unit, Policlinico San Martino, Genova, Italy
Vol. 103 No. 1 (2018): January, 2018 https://doi.org/10.3324/haematol.2017.176248